Asceneuron Pty Ltd.: Clinical Trials

1 trial sponsored by Asceneuron Pty Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Asceneuron Pty Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease
ASN51, Placebo - Alzheimer Disease
Phase 1TerminatedAsceneuron Pty Ltd.252021-06-022023-01-17

Conditions studied

Alzheimer Disease (1)

Countries

Australia (1)